Global Peptide Therapeutics Market is Predicted to Reach USD 103 Billion By 2030 Registering a CAGR of 10% | Infinium Global Research

Infinium Global Research has unveiled an extensive report detailing segments and sub-segments within the Global Peptide Therapeutics Market. The comprehensive study delves into the impact of drivers, restraints, and macro indicators, projecting short and long-term market trends, forecasts, and dollar values.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/628

Market Insight:

The global peptide therapeutics market, valued at approximately USD 45 billion in 2022, is projected to escalate to nearly USD 103 billion by 2030, exhibiting a robust CAGR of around 10% during the forecast period from 2023 to 2030.

Peptides, short chains of amino acids with diverse cellular functions, hold immense therapeutic potential. Their utility in combatting infections and signaling processes drives market growth. The market's trajectory is bolstered by the rising prevalence of metabolic disorders and cancer, escalated investments in R&D for new drugs, and advancements in peptide therapeutic technologies. Chronic diseases like diabetes, cardiovascular diseases, and cancer have been reported as major causes of global death and disability, fueling the demand for peptide therapeutics.

Market Dynamics:

Recent years have witnessed substantial growth in the global peptide therapeutics market due to surging cancer cases and increasing metabolic disorders. The market is poised for continued expansion driven by ongoing research activities and novel drug development. However, stringent regulatory processes for drug approval might pose challenges. Nevertheless, the rising incidence of metabolic disorders globally is anticipated to present multiple growth opportunities. Market players focus on developing innovative peptide-based drugs to address unmet medical needs, further propelled by advancements in drug delivery systems and technologies.

Regional Analysis:

North America holds the largest market share and is expected to maintain its dominance owing to increased awareness of peptide-based therapeutics and a thriving biotechnology sector. Europe, the second-largest market, experiences growth due to emerging pharmaceutical and biotech firms. Meanwhile, Asia-Pacific is poised to exhibit the highest CAGR in the upcoming years, attributed to sophisticated healthcare infrastructure and a rising population of cancer patients and metabolic disorders.

Segments Covered:

The report segments the global peptide therapeutics market based on product type (generic, branded), application (gastrointestinal disorders, neurological disorders, cancer, etc.), and route of administration (parenteral, oral, etc.).

Companies Profiled:

Key market players such as Teva Pharmaceutical Industries Ltd., Pfizer Inc., GSK plc, and others are extensively profiled in the report, offering insights into their contributions shaping the evolving peptide therapeutics market.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/628

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Peptide Therapeutics Market Highlights

2.2. Peptide Therapeutics Market Projection

2.3. Peptide Therapeutics Market Regional Highlights

Chapter 3. Global Peptide Therapeutics Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Product Type

3.4.2. IGR-Growth Matrix Analysis by Application

3.4.3. IGR-Growth Matrix Analysis by Route of Administration

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Peptide Therapeutics Market

Chapter 4. Peptide Therapeutics Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Peptide Therapeutics Market

5.2. Companies Profiles

5.2.1. Teva Pharmaceutical Industries Ltd.

5.2.2. Takeda Pharmaceutical Company Limited

5.2.3. Sanofi

5.2.4. Pfizer Inc.

5.2.5. Novartis AG

5.2.6. GSK plc

5.2.7. F. Hoffmann-La Roche Ltd

5.2.8. Lilly

5.2.9. Bachem

5.2.10. Amgen Inc.

Chapter 6. Global Peptide Therapeutics Market by Product Type

6.1. Generic

6.2. Branded

Chapter 7. Global Peptide Therapeutics Market by Application

7.1. Gastrointestinal Disorders

7.2. Neurological Disorders

7.3. Metabolic Disorders

7.4. Cancer

7.5. Other Applications

Chapter 8. Global Peptide Therapeutics Market by Route of Administration

8.1. Parenteral

8.2. Oral

8.3. Other Routes of Administration

Chapter 9. Global Peptide Therapeutics Market by Region 2023-2030

9.1. North America

9.1.1. North America Peptide Therapeutics Market by Product Type

9.1.2. North America Peptide Therapeutics Market by Application

9.1.3. North America Peptide Therapeutics Market by Route of Administration

9.1.4. North America Peptide Therapeutics Market by Country

9.1.4.1. The U.S. Peptide Therapeutics Market

9.1.4.1.1. The U.S. Peptide Therapeutics Market by Product Type

9.1.4.1.2. The U.S. Peptide Therapeutics Market by Application

9.1.4.1.3. The U.S. Peptide Therapeutics Market by Route of Administration

9.1.4.2. Canada Peptide Therapeutics Market

9.1.4.2.1. Canada Peptide Therapeutics Market by Product Type

9.1.4.2.2. Canada Peptide Therapeutics Market by Application

9.1.4.2.3. Canada Peptide Therapeutics Market by Route of Administration

9.1.4.3. Mexico Peptide Therapeutics Market

9.1.4.3.1. Mexico Peptide Therapeutics Market by Product Type

9.1.4.3.2. Mexico Peptide Therapeutics Market by Application

9.1.4.3.3. Mexico Peptide Therapeutics Market by Route of Administration

9.2. Europe

9.2.1. Europe Peptide Therapeutics Market by Product Type

9.2.2. Europe Peptide Therapeutics Market by Application

9.2.3. Europe Peptide Therapeutics Market by Route of Administration

9.2.4. Europe Peptide Therapeutics Market by Country

9.2.4.1. Germany Peptide Therapeutics Market

9.2.4.1.1. Germany Peptide Therapeutics Market by Product Type

9.2.4.1.2. Germany Peptide Therapeutics Market by Application

9.2.4.1.3. Germany Peptide Therapeutics Market by Route of Administration

9.2.4.2. United Kingdom Peptide Therapeutics Market

9.2.4.2.1. United Kingdom Peptide Therapeutics Market by Product Type

9.2.4.2.2. United Kingdom Peptide Therapeutics Market by Application

9.2.4.2.3. United Kingdom Peptide Therapeutics Market by Route of Administration

9.2.4.3. France Peptide Therapeutics Market

9.2.4.3.1. France Peptide Therapeutics Market by Product Type

9.2.4.3.2. France Peptide Therapeutics Market by Application

9.2.4.3.3. France Peptide Therapeutics Market by Route of Administration

9.2.4.4. Italy Peptide Therapeutics Market

9.2.4.4.1. Italy Peptide Therapeutics Market by Product Type

9.2.4.4.2. Italy Peptide Therapeutics Market by Application

9.2.4.4.3. Italy Peptide Therapeutics Market by Route of Administration

9.2.4.5. Rest of Europe Peptide Therapeutics Market

9.2.4.5.1. Rest of Europe Peptide Therapeutics Market by Product Type

9.2.4.5.2. Rest of Europe Peptide Therapeutics Market by Application

9.2.4.5.3. Rest of Europe Peptide Therapeutics Market by Route of Administration

9.3. Asia Pacific

9.3.1. Asia Pacific Peptide Therapeutics Market by Product Type

9.3.2. Asia Pacific Peptide Therapeutics Market by Application

9.3.3. Asia Pacific Peptide Therapeutics Market by Route of Administration

9.3.4. Asia Pacific Peptide Therapeutics Market by Country

9.3.4.1. China Peptide Therapeutics Market

9.3.4.1.1. China Peptide Therapeutics Market by Product Type

9.3.4.1.2. China Peptide Therapeutics Market by Application

9.3.4.1.3. China Peptide Therapeutics Market by Route of Administration

9.3.4.2. Japan Peptide Therapeutics Market

9.3.4.2.1. Japan Peptide Therapeutics Market by Product Type

9.3.4.2.2. Japan Peptide Therapeutics Market by Application

9.3.4.2.3. Japan Peptide Therapeutics Market by Route of Administration

9.3.4.3. India Peptide Therapeutics Market

9.3.4.3.1. India Peptide Therapeutics Market by Product Type

9.3.4.3.2. India Peptide Therapeutics Market by Application

9.3.4.3.3. India Peptide Therapeutics Market by Route of Administration

9.3.4.4. South Korea Peptide Therapeutics Market

9.3.4.4.1. South Korea Peptide Therapeutics Market by Product Type

9.3.4.4.2. South Korea Peptide Therapeutics Market by Application

9.3.4.4.3. South Korea Peptide Therapeutics Market by Route of Administration

9.3.4.5. Australia Peptide Therapeutics Market

9.3.4.5.1. Australia Peptide Therapeutics Market by Product Type

9.3.4.5.2. Australia Peptide Therapeutics Market by Application

9.3.4.5.3. Australia Peptide Therapeutics Market by Route of Administration

9.3.4.6. Rest of Asia-Pacific Peptide Therapeutics Market

9.3.4.6.1. Rest of Asia-Pacific Peptide Therapeutics Market by Product Type

9.3.4.6.2. Rest of Asia-Pacific Peptide Therapeutics Market by Application

9.3.4.6.3. Rest of Asia-Pacific Peptide Therapeutics Market by Route of Administration

9.4. RoW

9.4.1. RoW Peptide Therapeutics Market by Product Type

9.4.2. RoW Peptide Therapeutics Market by Application

9.4.3. RoW Peptide Therapeutics Market by Route of Administration

9.4.4. RoW Peptide Therapeutics Market by Sub-region

9.4.4.1. Latin America Peptide Therapeutics Market

9.4.4.1.1. Latin America Peptide Therapeutics Market by Product Type

9.4.4.1.2. Latin America Peptide Therapeutics Market by Application

9.4.4.1.3. Latin America Peptide Therapeutics Market by Route of Administration

9.4.4.2. Middle East Peptide Therapeutics Market

9.4.4.2.1. Middle East Peptide Therapeutics Market by Product Type

9.4.4.2.2. Middle East Peptide Therapeutics Market by Application

9.4.4.2.3. Middle East Peptide Therapeutics Market by Route of Administration

9.4.4.3. Africa Peptide Therapeutics Market

9.4.4.3.1. Africa Peptide Therapeutics Market by Product Type

9.4.4.3.2. Africa Peptide Therapeutics Market by Application

9.4.4.3.3. Africa Peptide Therapeutics Market by Route of Administration

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/628

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of peptide therapeutics.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.